title: [Management of hyperhidrosis].
abstract: Hyperhidrosis continues to be undertreated in our view, despite its propensity to considerably impair quality of life. We shall break down therapeutic approaches to hyperhidrosis into several steps: (a) determine the physiological causes of excess sweating; (b) establish the type of hyperhidrosis involved and screen for causes of secondary hyperhidrosis before diagnosing essential hyperhidrosis; (c) evaluate the severity of the hyperhidrosis by means of a validated scale (HDSS score), Minor's starch-iodine test or gravimetric analysis; (d) select one of the medical therapies currently available, i.e. topical therapy (antiperspirants, iontophoresis or botulinum toxin injection), systemic therapy (oxybutynin) or surgery (thoracic sympathectomy).
authors.affiliation: Service de dermatologie, centre hospitalier général du Mans, 194, avenue Rubillard, 72037 Le Mans cedex, France. Electronic address: hmaillard@ch-lemans.fr.
authors.forename: H
authors.initials: H
authors.lastname: Maillard
authors.affiliation: Service de dermatologie, centre hospitalier général du Mans, 194, avenue Rubillard, 72037 Le Mans cedex, France.
authors.forename: M
authors.initials: M
authors.lastname: Lecouflet
mesh_terms: D000465:Algorithms; D051520:Antiperspirants / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003663:Decision Trees; D019468:Disease Management; D006801:Humans; D006945:Hyperhidrosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D007478:Iontophoresis; D012720:Severity of Illness Index; D013194:Staining and Labeling; D013545:Sweat Glands / Q000503:physiopathology; D013562:Sympathectomy
chemical_list: D051520:Antiperspirants; D018680:Cholinergic Antagonists; D019274:Botulinum Toxins, Type A
keywords: Antiperspirants; Botulinum toxin; Hyperhidrose; Hyperhidrosis; Ionophorèse; Iontophoresis; Oxybutynin; Oxybutynine; Toxine botulique